InnovAge Holding Corp.
General ticker "INNV" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $783.4M (TTM average)
InnovAge Holding Corp. follows the US Stock Market performance with the rate: 45.9%.
Estimated limits based on current volatility of 2.9%: low 11.23$, high 11.91$
Factors to consider:
- Total employees count: 2440 (+3.8%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Regulatory and compliance, Participant retention, Acquisition/divestiture risks, Government payor dependence, Capital raising failure
- Current price 95.5% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-06-30 to 2027-06-30
- 2025-06-30 to 2026-06-30 estimated range: [2.44$, 5.53$]
- 2026-06-30 to 2027-06-30 estimated range: [2.67$, 5.88$]
Financial Metrics affecting the INNV estimates:
- Positive: with PPE of -16.7 at the end of fiscal year the price was neutral
- Positive: -5.34 < Operating profit margin, % of -3.37
- Positive: -4.39 < Investing cash flow per share per price, % of -1.07
- Positive: -0.03 < Operating cash flow per share per price, % of 6.31
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: -9.70 < Industry operating profit margin (median), % of -3.22
- Positive: 42.57 < Shareholder equity ratio, % of 44.60 <= 64.23
- Positive: -0.03 < Industry operating cash flow per share per price (median), % of 2.92
Short-term INNV quotes
Long-term INNV plot with estimates
Financial data
| YTD | 2023-06-30 | 2024-06-30 | 2025-06-30 |
|---|---|---|---|
| Operating Revenue | $688.09MM | $763.86MM | $853.70MM |
| Operating Expenses | $737.48MM | $787.03MM | $883.46MM |
| Operating Income | $-49.40MM | $-23.18MM | $-29.76MM |
| Non-Operating Income | $-1.40MM | $1.36MM | $-4.27MM |
| Interest Expense | $1.52MM | $4.02MM | $4.61MM |
| Income(Loss) | $-50.79MM | $-21.82MM | $-34.03MM |
| Taxes | $-7.24MM | $1.40MM | $1.32MM |
| Net Income(Loss)* | $-40.67MM | $-21.34MM | $-30.31MM |
| Stockholders Equity | $296.30MM | $269.26MM | $234.97MM |
| Assets | $567.36MM | $547.66MM | $526.85MM |
| Operating Cash Flow | $20.24MM | $-36.90MM | $32.87MM |
| Capital expenditure | $7.91MM | $7.91MM | $6.26MM |
| Investing Cash Flow | $-69.52MM | $-26.37MM | $-5.55MM |
| Financing Cash Flow | $-7.90MM | $-7.03MM | $-19.08MM |
| Earnings Per Share** | $-0.30 | $-0.16 | $-0.22 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.